Home

When heart fails to pump out sufficient blood to the rest of the body as demanded, most often caused by heart attack and high blood pressure, heart muscles will be damaged. This is a condition called heart failure. Most people with heart failure complain of breathing difficulty that may happen during exercise, eating or even sleeping. Other common symptoms and signs are lethargy, ankle swelling, abdominal bloating, frequent urination and memory impairment.

Patient with heart failure also have a poor prognosis and high risk of developing dangerous heart rhythms triggered by the damaged tissue inside the heart.

Current established treatment includes medications that have been proven to alleviate symptoms and reduce the risk of death. Furthermore if the heart damage were caused by blockage of artery, then angioplasty or heart bypass operation may help as they can restore blood supply to parts of the heart that is starved of oxygen. Unfortunately none of the conventional and current treatments above could regenerate new heart muscle to replace the permanently damaged ones caused by previous heart attacks. Hence there will always be some degree of heart failure and progressive deterioration in health.

For patient with heart failure, Cardiocell treatment will repair damaged cells and provide growth of new heart muscle, hence increase the overall strength of heart and alleviate heart failure. In addition, Cardiocell replaces the scarred portions of the damaged heart with viable muscle. As these scarred areas can trigger dangerous heart rhythms and cause cardiac arrest, by replacing the scar tissue, Cardiocell not only improves heart failure but also reduces the risk of sudden death from cardiac arrest.

In studies using cells identical to Cardiocell for heart failure, patients benefited from symptom relief, improved exercise capacity and stamina, and reduction of angina. There is evidence of increased heart strength and contractility, reduction of heart swelling and scar tissue.

Cardiocell allows the heart to repair and reverse its damage that current conventional treatment cannot provide. It is therefore complementary to conventional heart failure therapy. It brings new hope and treatment option for heart failure patients who remain ill in spite of, or are ineligible for, current treatments.

Generally if you had a heart attack in the last 2 years which has resulted in severe heart failure now and you have exhausted current methods of treatment, then you may be eligible for CardiocellTM treatment. We welcome your participation in CardiocellTM pilot programme as part of Cytopeutics clinical study. However, you should consult your regular doctor or cardiologist to determine your eligibility criteria.

View patient brochure

See the original post here:
Stem Cell Treatment For Heart And Knee : Cytopeutics

Comments are closed.